Company page

G2gbio, Inc.

G2gbio, Inc. is a public company listed under the ticker 456160 on the Korean market. The company has a market capitalization of approximately 690.97 billion KRW. G2gbio focuses on biotechnological advancements and innovations in the healthcare sector.